✦ LIBER ✦

Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease

✍ Scribed by Millie D. Long; Wallace V. Crandall; Ian H. Leibowitz; Lynn Duffy; Fernando del Rosario; Sandra C. Kim; Mark J. Integlia; James Berman; John Grunow; Richard B. Colletti; Bess T. Schoen; Ashish S. Patel; Howard Baron; Esther Israel; George Russell; Sabina Ali; Hans H. Herfarth; Christopher Martin; Michael D. Kappelman; on behalf of the ImproveCareNow Collaborative for Pediatric IBD

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 96 KB
Volume: 17
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.21585

No coin nor oath required. For personal study only.

✦ Synopsis

Background:

Obesity is a significant public health threat to children in the united states. the aims were to: 1) determine the prevalence of obesity in a multicenter cohort of children with inflammatory bowel disease (ibd); 2) evaluate whether overweight and obese status is associated with patient demographics or disease characteristics.

Methods:

We used data from the improvecarenow collaborative for pediatric ibd, a multicenter registry of children with ibd, collected between april 2007 and december 2009. children ages 2-18 years were classified into body mass index (bmi) percentiles. bivariate analyses and multivariate logistic regression were used to compare demographic and disease characteristics by overweight (bmi >85%) and obese (bmi >95%) status.

Results:

The population consisted of 1598 children with ibd. the prevalence of overweight/obese status in pediatric ibd is 23.6%, (20.0% for crohn's disease [cd] and 30.1% for ulcerative colitis [uc] and indeterminate colitis [ic]). african american race (odds ratio [or] 1.64, 95% confidence interval [ci] 1.10-2.48) and medicaid insurance (or 1.67, 95% ci 1.19-2.34) were positively associated with overweight/obese status. prior ibd-related surgery (or 1.73, 95% ci 1.07-2.82) was also associated with overweight and obese status in children with cd. other disease characteristics were not associated with overweight and obesity in children with ibd.

Conclusions:

Approximately one in five children with cd and one in three with uc are overweight or obese. rates of obesity in uc are comparable to the general population. obese ibd patients may have a more severe disease course, as indicated by increased need for surgery. sociodemographic risk factors for obesity in the ibd population are similar to those in the general population.

📜 SIMILAR VOLUMES

Clinical epidemiology of inflammatory bo

Clinical epidemiology of inflammatory bowel disease in Lebanon

✍ Heitham Abdul-Baki; Ihab ElHajj; Lara MN El-Zahabi; Cecilio Azar; Elie Aoun; Hal 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

## Background: The objectives of this study were to determine the prevalence and incidence of inflammatory bowel disease (ibd) in a representative lebanese cohort and to describe practice prevalence trends, disease characteristics, and impact on quality of life (qol) of ibd patients in lebanon. ##

Presenting symptoms and diagnostic lag i

Presenting symptoms and diagnostic lag in children with inflammatory bowel disease

✍ Janice B. Heikenen; Dr. Steven L. Werlin; Christopher W. Brown; Jane P. Balint 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB 👁 2 views

Presenting symptoms and their duration may affect the time that elapses prior to definitive diagnosis of intlammatory bowel disease (IBD). This study was undertaken to determine the mean duration of presenting symptoms and diagnostic lag in children with IBD. The medical records of all patients less

Immunogenicity and safety of influenza v

Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease

✍ Jennifer C.C. deBruyn; Robert Hilsden; Kevin Fonseca; Margaret L. Russell; Gilaa 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 2 views

Background: Protection against vaccine-preventable diseases is important in inflammatory bowel disease (IBD) because of increased susceptibility and severity of infection with immunosuppressive therapy. However, immunosuppressive therapy may affect vaccine response. This study aimed to evaluate immu

Inflammatory bowel disease: Incidence, p

Inflammatory bowel disease: Incidence, prevalence, and disease characteristics in Barbados, West Indies

✍ C.N. Edwards; S.G. Griffith; A.J. Hennis; I.R. Hambleton 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Background: The incidence of inflammatory bowel disease (IBD) may be lower among people of African descent than Caucasians. However, incidence studies among the former are uncommon and are often limited by incomplete case ascertainment or uncertainty about the size of the "at-risk" population.

Risk of diagnosed fractures in children

Risk of diagnosed fractures in children with inflammatory bowel diseases

✍ Michael D. Kappelman; Joseph A. Galanko; Carol Q. Porter; Robert S. Sandler 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 2 views

## Background: Decreased bone mass is common in children with inflammatory bowel disease (ibd); however, fracture risk is unknown. we sought to evaluate fracture risk in children with ibd as compared to unaffected controls and determine whether this risk is affected by geographical region (a proxy

Enteric viral pathogens in children with

Enteric viral pathogens in children with inflammatory bowel disease

✍ Kaija-Leena Kolho; Päivi Klemola; Marja-Leena Simonen-Tikka; Marja-Liisa Ollonen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 1 views

## Abstract The causes of exacerbations of inflammatory bowel disease (IBD) are unknown. The presence of RNA of an enterovirus, norovirus GI, norovirus GII, rotavirus, astrovirus, and sapovirus was sought in stool samples of 50 children (median age 12.9 years) undergoing gastrointestinal endoscopie